New Type of Opioid Reversal Agent Approved

(MedPage Today) -- The first nalmefene hydrochloride nasal spray (Opvee) won FDA approval for the emergency treatment of known or suspected opioid overdose in adults and pediatric patients 12 years of age and up, the agency announced. If administered...
Source: MedPage Today Neurology - Category: Neurology Source Type: news